Literature DB >> 15485649

ZAK re-programs atrial natriuretic factor expression and induces hypertrophic growth in H9c2 cardiomyoblast cells.

Chih-Yang Huang1, Pin Ju Chueh, Chien-Tang Tseng, Kuan-Yu Liu, Hsiao-Ya Tsai, Wei-Wen Kuo, Ming-Yung Chou, Jaw-Ji Yang.   

Abstract

Various intracellular or intercellular stimuli have been associated with the development of cardiac cell hypertrophy. However, the mechanisms underlying this association are not completely understood. In a previous study we determined that ZAK mRNA expression is abundant in heart. ZAK is a mitogen-activated protein kinase kinase kinase (MAP3K) that activates the stress-activated protein kinase/c-jun N-terminal kinase pathway and activates NF-kappaB. We, therefore, investigated the potential involvement of ZAK (which in cultured H9c2 cardiomyoblast cell is a positive mediator of cell hypertrophy). Our results showed that the expression of a wild-type form of ZAK induces the characteristic hypertrophic growth features, including increased cell size, elevated atrial natriuretic factor expression, and increased actin fiber organization.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15485649     DOI: 10.1016/j.bbrc.2004.09.156

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  12 in total

1.  Regulation of mixed-lineage kinase activation in JNK-dependent morphogenesis.

Authors:  Rebecca A Garlena; Rebecca L Gonda; Alyssa B Green; Rachel M Pileggi; Beth Stronach
Journal:  J Cell Sci       Date:  2010-08-24       Impact factor: 5.285

2.  ZAK induces cardiomyocyte hypertrophy and brain natriuretic peptide expression via p38/JNK signaling and GATA4/c-Jun transcriptional factor activation.

Authors:  You-Liang Hsieh; Ying-Lan Tsai; Marthandam Asokan Shibu; Chia-Chi Su; Li-Chin Chung; Peiying Pai; Chia-Hua Kuo; Yu-Lan Yeh; Vijaya Padma Viswanadha; Chih-Yang Huang
Journal:  Mol Cell Biochem       Date:  2015-04-14       Impact factor: 3.396

3.  The H9C2 cell line and primary neonatal cardiomyocyte cells show similar hypertrophic responses in vitro.

Authors:  Sarah J Watkins; Gillian M Borthwick; Helen M Arthur
Journal:  In Vitro Cell Dev Biol Anim       Date:  2010-11-17       Impact factor: 2.416

4.  ZAK induces MMP-2 activity via JNK/p38 signals and reduces MMP-9 activity by increasing TIMP-1/2 expression in H9c2 cardiomyoblast cells.

Authors:  Yi-Chang Cheng; Wei-Wen Kuo; Hsi-Chin Wu; Tung-Yuan Lai; Chun-Hsien Wu; Jin-Ming Hwang; Wen-Hong Wang; Fuu-Jen Tsai; Jaw-Ji Yang; Chih-Yang Huang; Chun-Hsien Chu
Journal:  Mol Cell Biochem       Date:  2009-01-28       Impact factor: 3.396

5.  The MAP3K ZAK, a novel modulator of ERK-dependent migration, is upregulated in colorectal cancer.

Authors:  C Rey; B Faustin; I Mahouche; R Ruggieri; C Brulard; F Ichas; I Soubeyran; L Lartigue; F De Giorgi
Journal:  Oncogene       Date:  2015-11-02       Impact factor: 9.867

6.  Recessive mutations in the kinase ZAK cause a congenital myopathy with fibre type disproportion.

Authors:  Nasim Vasli; Elizabeth Harris; Jason Karamchandani; Eric Bareke; Jacek Majewski; Norma B Romero; Tanya Stojkovic; Rita Barresi; Hichem Tasfaout; Richard Charlton; Edoardo Malfatti; Johann Bohm; Chiara Marini-Bettolo; Karine Choquet; Marie-Josée Dicaire; Yi-Hong Shao; Ana Topf; Erin O'Ferrall; Bruno Eymard; Volker Straub; Gonzalo Blanco; Hanns Lochmüller; Bernard Brais; Jocelyn Laporte; Martine Tétreault
Journal:  Brain       Date:  2016-11-05       Impact factor: 13.501

7.  BRAF inhibitors suppress apoptosis through off-target inhibition of JNK signaling.

Authors:  Harina Vin; Sandra S Ojeda; Grace Ching; Marco L Leung; Vida Chitsazzadeh; David W Dwyer; Charles H Adelmann; Monica Restrepo; Kristen N Richards; Larissa R Stewart; Lili Du; Scarlett B Ferguson; Deepavali Chakravarti; Karin Ehrenreiter; Manuela Baccarini; Rosamaria Ruggieri; Jonathan L Curry; Kevin B Kim; Ana M Ciurea; Madeleine Duvic; Victor G Prieto; Stephen E Ullrich; Kevin N Dalby; Elsa R Flores; Kenneth Y Tsai
Journal:  Elife       Date:  2013-11-05       Impact factor: 8.140

8.  A Requirement for ZAK Kinase Activity in Canonical TGF-β Signaling.

Authors:  Shyam Nyati; Areeb Chator; Katerina Schinske; Brandon S Gregg; Brian Dale Ross; Alnawaz Rehemtulla
Journal:  Transl Oncol       Date:  2016-10-23       Impact factor: 4.243

9.  ZAK negatively regulates RhoGDIbeta-induced Rac1-mediated hypertrophic growth and cell migration.

Authors:  Chih-Yang Huang; Li-Chiu Yang; Kuan-Yu Liu; I-Chang Chang; Pao-Hsin Liao; Janet Ing-Yuh Chou; Ming-Yung Chou; Wei-Wen Lin; Jaw-Ji Yang
Journal:  J Biomed Sci       Date:  2009-06-18       Impact factor: 8.410

10.  RhoGDIbeta-induced hypertrophic growth in H9c2 cells is negatively regulated by ZAK.

Authors:  Chih-Yang Huang; Li-Chiu Yang; Kuan-Yu Liu; Pao-Hsin Liao; Janet Ing-Yuh Chou; Ming-Yung Chou; Wei-Wen Lin; Jaw-Ji Yang
Journal:  J Biomed Sci       Date:  2009-01-22       Impact factor: 8.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.